Results
|
2761.
|
|
|
2762.
|
|
|
2763.
|
|
|
2764.
|
Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support. [electronic resource] by
- Quintela-Fandino, Miguel
- López, Joaquín Martínez
- Hitt, Ricardo
- Gamarra, Soledad
- Jimeno, Antonio
- Ayala, Rosa
- Hornedo, Javier
- Guzman, Cecilia
- Gilsanz, Florinda
- Cortés-Funes, Hernán
Producer: 20060814
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 24
Availability: No items available.
|
|
2765.
|
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. [electronic resource] by
- Pegram, M
- Hsu, S
- Lewis, G
- Pietras, R
- Beryt, M
- Sliwkowski, M
- Coombs, D
- Baly, D
- Kabbinavar, F
- Slamon, D
Producer: 19990526
In:
Oncogene vol. 18
Availability: No items available.
|
|
2766.
|
The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease. [electronic resource] by
- de Graaf, H
- Mulder, N H
- Willemse, P H
- van der Graaf, W T
- Sleijfer, D T
- Zijlstra, J G
- Elias, M
- Sibinga, C T
- Vellenga, E
- de Vries, E G
Producer: 19960807
In:
Anticancer research vol. 15
Availability: No items available.
|
|
2767.
|
Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia. [electronic resource] by
- Bacigalupo, A
- Van Lint, M T
- Valbonesi, M
- Lercari, G
- Carlier, P
- Lamparelli, T
- Gualandi, F
- Occhini, D
- Bregante, S
- Valeriani, A
- Piaggio, G
- Pitto, A
- Benvenuto, F
- Figari, O
- De Stefano, G
- Caimo, A
- Sessarego, M
Producer: 19960909
In:
Blood vol. 88
Availability: No items available.
|
|
2768.
|
|
|
2769.
|
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. [electronic resource] by
- Ferreri, Andrés J M
- Cwynarski, Kate
- Pulczynski, Elisa
- Ponzoni, Maurilio
- Deckert, Martina
- Politi, Letterio S
- Torri, Valter
- Fox, Christopher P
- Rosée, Paul La
- Schorb, Elisabeth
- Ambrosetti, Achille
- Roth, Alexander
- Hemmaway, Claire
- Ferrari, Angela
- Linton, Kim M
- Rudà, Roberta
- Binder, Mascha
- Pukrop, Tobias
- Balzarotti, Monica
- Fabbri, Alberto
- Johnson, Peter
- Gørløv, Jette Sønderskov
- Hess, Georg
- Panse, Jens
- Pisani, Francesco
- Tucci, Alessandra
- Stilgenbauer, Stephan
- Hertenstein, Bernd
- Keller, Ulrich
- Krause, Stefan W
- Levis, Alessandro
- Schmoll, Hans J
- Cavalli, Franco
- Finke, Jürgen
- Reni, Michele
- Zucca, Emanuele
- Illerhaus, Gerald
Producer: 20180126
In:
The Lancet. Haematology vol. 3
Availability: No items available.
|